BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10047579)

  • 1. Folding of peptide models of collagen and misfolding in disease.
    Baum J; Brodsky B
    Curr Opin Struct Biol; 1999 Feb; 9(1):122-8. PubMed ID: 10047579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of the mechanism of triple-helix peptide folding in the absence of a C-terminal nucleation domain and its implications for mutations in collagen disorders.
    Buevich AV; Silva T; Brodsky B; Baum J
    J Biol Chem; 2004 Nov; 279(45):46890-5. PubMed ID: 15299012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear magnetic resonance shows asymmetric loss of triple helix in peptides modeling a collagen mutation in brittle bone disease.
    Liu X; Kim S; Dai QH; Brodsky B; Baum J
    Biochemistry; 1998 Nov; 37(44):15528-33. PubMed ID: 9799516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteogenesis imperfecta collagen-like peptides: self-assembly and mineralization on surfaces.
    Xu P; Huang J; Cebe P; Kaplan DL
    Biomacromolecules; 2008 Jun; 9(6):1551-7. PubMed ID: 18498187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time NMR investigations of triple-helix folding and collagen folding diseases.
    Baum J; Brodsky B
    Fold Des; 1997; 2(4):R53-60. PubMed ID: 9269560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear magnetic resonance characterization of peptide models of collagen-folding diseases.
    Buevich A; Baum J
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):159-68. PubMed ID: 11260796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid sequence environment modulates the disruption by osteogenesis imperfecta glycine substitutions in collagen-like peptides.
    Yang W; Battineni ML; Brodsky B
    Biochemistry; 1997 Jun; 36(23):6930-5. PubMed ID: 9188687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen.
    Bächinger HP; Morris NP; Davis JM
    Am J Med Genet; 1993 Jan; 45(2):152-62. PubMed ID: 8456797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence environment of mutation affects stability and folding in collagen model peptides of osteogenesis imperfecta.
    Bryan MA; Cheng H; Brodsky B
    Biopolymers; 2011; 96(1):4-13. PubMed ID: 20235194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant collagen studies link the severe conformational changes induced by osteogenesis imperfecta mutations to the disruption of a set of interchain salt bridges.
    Xu K; Nowak I; Kirchner M; Xu Y
    J Biol Chem; 2008 Dec; 283(49):34337-44. PubMed ID: 18845533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR conformational and dynamic consequences of a gly to ser substitution in an osteogenesis imperfecta collagen model peptide.
    Li Y; Brodsky B; Baum J
    J Biol Chem; 2009 Jul; 284(31):20660-7. PubMed ID: 19451653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteogenesis imperfecta model peptides: incorporation of residues replacing Gly within a triple helix achieved by renucleation and local flexibility.
    Xiao J; Madhan B; Li Y; Brodsky B; Baum J
    Biophys J; 2011 Jul; 101(2):449-58. PubMed ID: 21767498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct NMR measurement of folding kinetics of a trimeric peptide.
    Liu X; Siegel DL; Fan P; Brodsky B; Baum J
    Biochemistry; 1996 Apr; 35(14):4306-13. PubMed ID: 8605179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence dependence of renucleation after a Gly mutation in model collagen peptides.
    Hyde TJ; Bryan MA; Brodsky B; Baum J
    J Biol Chem; 2006 Dec; 281(48):36937-43. PubMed ID: 16998200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of osteogenesis imperfecta and structure of a collagen-like peptide modeling a lethal mutation site.
    Radmer RJ; Klein TE
    Biochemistry; 2004 May; 43(18):5314-23. PubMed ID: 15122897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular abnormalities of collagen: a review.
    Pope FM; Nicholls AC; Dorling J; Webb J
    J R Soc Med; 1983 Dec; 76(12):1050-62. PubMed ID: 6368819
    [No Abstract]   [Full Text] [Related]  

  • 17. CD and NMR investigation of collagen peptides mimicking a pathological Gly-Ser mutation and a natural interruption in a similar highly charged sequence context.
    Sun X; Liu S; Yu W; Wang S; Xiao J
    Protein Sci; 2016 Feb; 25(2):383-92. PubMed ID: 26457583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The folding mechanism of collagen-like model peptides explored through detailed molecular simulations.
    Stultz CM
    Protein Sci; 2006 Sep; 15(9):2166-77. PubMed ID: 16943446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the clinical lethality of osteogenesis imperfecta from collagen glycine mutations.
    Bodian DL; Madhan B; Brodsky B; Klein TE
    Biochemistry; 2008 May; 47(19):5424-32. PubMed ID: 18412368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupting Effects of Osteogenesis Imperfecta Mutations Could Be Predicted by Local Hydrogen Bonding Energy.
    Qiang S; Lu C; Xu F
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.